Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Diabetes Mellitus peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Diabetes Mellitus. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
5 profiles.
2016–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 139 selected PubMed records and 5 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Diabetes Mellitus unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01452451
PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 9, 2016
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01777282
PeptideScanner retained ClinicalTrials.gov record NCT01777282 at 2026-11-16T17:45:42.793Z. Its registry update date was 2017-05-03, and PeptideScanner's reviewed identity mapping was albiglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 3, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05659147
PeptideScanner retained ClinicalTrials.gov record NCT05659147 at 2026-11-16T01:34:15.953Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was secretin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 18, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Tirzepatide · 2026-07-20
ClinicalTrials.gov record NCT07707778
Enrolling by invitation at the retained observation.
Open attributed record →Secretin · 2026-03-18
ClinicalTrials.gov record NCT05659147
Enrolling by invitation at the retained observation.
Open attributed record →Lixisenatide · 2017-11-29
ClinicalTrials.gov record NCT02745470
Completed at the retained observation.
Open attributed record →Albiglutide · 2017-05-03
ClinicalTrials.gov record NCT01777282
Completed at the retained observation.
Open attributed record →Efpeglenatide · 2016-08-09
ClinicalTrials.gov record NCT01452451
Completed at the retained observation.
Open attributed record →